MedinCell S.A. (EPA:MEDCL)
France · Delayed Price · Currency is EUR 34.58
+0.68 (2.01%)
Oct 20, 2025, 1:44 PM CET
MedinCell Market Cap
MedinCell has a market cap or net worth of €1.12 billion as of October 20, 2025. Its market cap has increased by 153.41% in one year.
Market Cap
1.12B
Enterprise Value
1.12B
Revenue
27.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
€34.58
Market Cap Chart
Since October 8, 2018, MedinCell's market cap has increased from 146.11M to 1.12B, an increase of 667.86%. That is a compound annual growth rate of 33.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 1.12B | 130.94% |
| Dec 31, 2024 | 485.79M | 134.93% |
| Dec 29, 2023 | 206.78M | 33.30% |
| Dec 30, 2022 | 155.12M | -37.61% |
| Dec 31, 2021 | 248.65M | 10.03% |
| Dec 31, 2020 | 225.98M | 63.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 144.11B |
| Sanofi | 105.17B |
| Sartorius Stedim Biotech | 19.71B |
| bioMérieux | 13.02B |
| Eurofins Scientific SE | 11.09B |
| Ipsen | 9.40B |
| ABIVAX Société Anonyme | 5.93B |
| Virbac | 2.79B |